RxDoctor Payments Data

Summer Jordan

Gerontology · Spring Hill, FLNPI 1386313039

Payments from drug & device makers

$5,044in general payments, 2019–2025

Across 201 payments — averaging $25.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$385
  • Merck$339
  • Novartis$310
  • Regeneron Healthcare Solutions, Inc.$307
  • Vertos Medical, Inc.$271
  • AstraZeneca$259
  • plus $3K from 43 others

What the payments were for

  • Food & beverage$4,45388%
  • Education$59112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,044 in reported general payments places this provider in the 90th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron22$16,520
GemtesaVibegron16$10,221
Tamsulosin Hcl106$1,717
Estradiol24$1,392
NitrofurantoinNitrofurantoin Macrocrystal35$992
Dutasteride11$715
Oxybutynin Chloride ErOxybutynin Chloride17$607
Finasteride18$302
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim48$249
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst21$177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$228$16,52022 claims
Sumitomo Pharma America, Inc.Gemtesa$20$10,22116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 714 gerontology providers in Florida.

Other gerontology in Spring Hill

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →